These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 8406826)

  • 1. Accelerated decay of C3b to iC3b when C3b is bound to the Cryptococcus neoformans capsule.
    Pfrommer GS; Dickens SM; Wilson MA; Young BJ; Kozel TR
    Infect Immun; 1993 Oct; 61(10):4360-6. PubMed ID: 8406826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation and binding of opsonic fragments of C3 on encapsulated Cryptococcus neoformans by using an alternative complement pathway reconstituted from six isolated proteins.
    Kozel TR; Wilson MA; Pfrommer GS; Schlageter AM
    Infect Immun; 1989 Jul; 57(7):1922-7. PubMed ID: 2525113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the complement system by Cryptococcus neoformans leads to binding of iC3b to the yeast.
    Kozel TR; Pfrommer GS
    Infect Immun; 1986 Apr; 52(1):1-5. PubMed ID: 3514450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of antibody in normal human serum to early deposition of C3 onto encapsulated and nonencapsulated Cryptococcus neoformans.
    Wilson MA; Kozel TR
    Infect Immun; 1992 Mar; 60(3):754-61. PubMed ID: 1541548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic analysis of the amplification phase for activation and binding of C3 to encapsulated and nonencapsulated Cryptococcus neoformans.
    Kozel TR; Wilson MA; Welch WH
    Infect Immun; 1992 Aug; 60(8):3122-7. PubMed ID: 1639481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deposition of C3b and iC3b onto particulate activators of the human complement system. Quantitation with monoclonal antibodies to human C3.
    Newman SL; Mikus LK
    J Exp Med; 1985 Jun; 161(6):1414-31. PubMed ID: 2409200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early events in initiation of alternative complement pathway activation by the capsule of Cryptococcus neoformans.
    Kozel TR; Wilson MA; Murphy JW
    Infect Immun; 1991 Sep; 59(9):3101-10. PubMed ID: 1831795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cleavage of complement C3b to iC3b on the surface of Staphylococcus aureus is mediated by serum complement factor I.
    Cunnion KM; Hair PS; Buescher ES
    Infect Immun; 2004 May; 72(5):2858-63. PubMed ID: 15102797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preimplantation embryos cooperate with oviductal cells to produce embryotrophic inactivated complement-3b.
    Tse PK; Lee YL; Chow WN; Luk JM; Lee KF; Yeung WS
    Endocrinology; 2008 Mar; 149(3):1268-76. PubMed ID: 18039777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strain variation in phagocytosis of Cryptococcus neoformans: dissociation of susceptibility to phagocytosis from activation and binding of opsonic fragments of C3.
    Kozel TR; Pfrommer GS; Guerlain AS; Highison BA; Highison GJ
    Infect Immun; 1988 Nov; 56(11):2794-800. PubMed ID: 3049374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of macrophage Fc and C3b receptors in phagocytosis of immunologically coated Cryptococcus neoformans.
    Griffin FM
    Proc Natl Acad Sci U S A; 1981 Jun; 78(6):3853-7. PubMed ID: 7022456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bovine conglutinin binds to an oligosaccharide determinant presented by iC3b, but not by C3, C3b or C3c.
    Laursen SB; Thiel S; Teisner B; Holmskov U; Wang Y; Sim RB; Jensenius JC
    Immunology; 1994 Apr; 81(4):648-54. PubMed ID: 7518801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of three different fragments of bound C3 with purified factor I or serum. II. Location of binding sites in the C3 fragments for factors B and H, complement receptors, and bovine conglutinin.
    Ross GD; Newman SL; Lambris JD; Devery-Pocius JE; Cain JA; Lachmann PJ
    J Exp Med; 1983 Aug; 158(2):334-52. PubMed ID: 6224880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel and sensitive functional assay for complement Factor I based on the third proteolytic clip of C3b.
    Lachmann PJ; Lay E; Seilly DJ
    J Immunol Methods; 2018 Jun; 457():30-32. PubMed ID: 29625075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-surface regulation of the human alternative pathway of complement. Sheep but not rabbit erythrocytes express factor I-dependent cofactor activity.
    Ezzell JL; Parker CJ
    Scand J Immunol; 1992 Jul; 36(1):79-87. PubMed ID: 1535452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylation of C3 by a casein kinase released from activated human platelets increases opsonization of immune complexes and binding to complement receptor type 1.
    Nilsson-Ekdahl K; Nilsson B
    Eur J Immunol; 2001 Apr; 31(4):1047-54. PubMed ID: 11298329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation and binding of C3 by Candida albicans.
    Kozel TR; Brown RR; Pfrommer GS
    Infect Immun; 1987 Aug; 55(8):1890-4. PubMed ID: 3301679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of strain variation, serotype, and structural modification on kinetics for activation and binding of C3 to Cryptococcus neoformans.
    Young BJ; Kozel TR
    Infect Immun; 1993 Jul; 61(7):2966-72. PubMed ID: 8514401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation, binding, and processing of complement component 3 (C3) by Blastomyces dermatitidis.
    Zhang MX; Klein B
    Infect Immun; 1997 May; 65(5):1849-55. PubMed ID: 9125571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formation of covalently linked C3-C3 dimers on IgG immune aggregates.
    Barrio E; Antón LC; Marqués G; Sánchez A; Vivanco F
    Eur J Immunol; 1991 Feb; 21(2):343-9. PubMed ID: 1999223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.